Author/Creator: Leitermann, Kate - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Leitermann, Kate

1. First‐in‐human, double‐blind, placebo‐controlled, single‐dose escalation study of aducanumab (BIIB037) in mild‐to‐moderate Alzheimer's disease. Issue 3 (20th June 2016)

Authors:: Ferrero, James; Williams, Leslie; Stella, Heather; Leitermann, Kate; Mikulskis, Alvydas; O'Gorman, John; Sevigny, Jeff
Journal:: Alzheimer's & dementia
Issue:: Volume 2:Issue 3(2016)
Page Start:: 169
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. P1–348: Pharmacokinetics of BIIB037 in people with mild‐to‐moderate Alzheimer's disease (AD) participating in a phase 1 dose‐escalation trial. (1st July 2013)

Authors:: Ferrero, Jim; Stella, Heather; Leitermann, Kate; Mikulskis, Alvy; Song, Tao; Sevigny, Jeff
Journal:: Alzheimer's & dementia
Issue:: Volume 9:Supplement 4S(2013)Part 7
Page Start:: P285
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. P1–359: A single ascending‐dose study of BIIB037 in people with mild‐to‐moderate Alzheimer's disease. (1st July 2013)

Authors:: Sevigny, Jeffrey; Williams, Leslie; Ferrero, Jim; Stella, Heather; Song, Tao; Leitermann, Kate; Mikulskis, Alvydas
Journal:: Alzheimer's & dementia
Issue:: Volume 9:Supplement 4S(2013)Part 7
Page Start:: P290
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗